Prediction of pathogenic mutations in patients with early-onset breast cancer by family history

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Ford, D., Easton, D., Stratton, M. R., Narod, S., Goldgar, D., Devilee, P., Bishop, D., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · American Journal of Human Genetics · doi:10.1086/301749 · Cited by 2,766

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases

Anglian Breast Cancer Study Group (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 602

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families

Birch, Hartley, Tricker, Prosser, P., Condie, Kelsey, Harris, Jones, Binchy, Crowther, et al. (1994) · Cancer Research · Cited by 475

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

Birch, J. M., Hartley, A. L., Tricker, K. J., Prosser, J., Condie, A., Kelsey, A. M., Harris, M., Jones, P. H. M., Binchy, A., & Crowther, D. (1994) · PubMed · Cited by 421

Breast and ovarian cancer incidence in BRCA1-mutation carriers

Easton, D., Ford, D., Bishop, D., Haites, N., Milner, B., Allan, L., Ponder, B., Peto, J., Smith, S., Ford, D., et al. (1995) · UCL Discovery (University College London) · Cited by 301

Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients

Çeçener, G., Takanlou, L. S., Takanlou, M. S., Egelí, Ü., Eskiler, G. G., Aksoy, S. A., Ünal, U., Tezcan-Unlu, H., Eryılmaz, I. E., Gökgöz, M. Ş., et al. (2019) · Cancer Genetics · doi:10.1016/j.cancergen.2019.10.004 · Cited by 17

Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers

Evans, D. G., Harkness, E. F., Howel, S., Woodward, E. R., Howell, A., & Lalloo, F. I. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4557-1 · Cited by 17

Systematic Analysis of Free-Text Family History in Electronic Health Record.

(2017) · PubMed Central · Cited by 16

Cancer surveillance for patients with Li-Fraumeni Syndrome in Brazil: A cost-effectiveness analysis

Frankenthal, I. A., Alves, M. C., Tak, C. R., & Achatz, M. I. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100265 · Cited by 15

Biogenic nanoparticles: pioneering a new era in breast cancer therapeutics—a comprehensive review

Bhat, S. A., Kumar, V., Dhanjal, D. S., Gandhi, Y., Mishra, S. K., Singh, S., Webster, T. J., & Ramamurthy, P. C. (2024) · Discover Nano · doi:10.1186/s11671-024-04072-y · Cited by 15

Families’ and health care professionals’ attitudes towards Li‐Fraumeni syndrome testing in children: A systematic review

Warby, M., Wakefield, C. E., Vetsch, J., & Tucker, K. (2018) · Clinical Genetics · doi:10.1111/cge.13442 · Cited by 15

Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome

Arai, H., Matsui, H., Chi, S., Utsu, Y., Masuda, S., Aotsuka, N., & Minami, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010652 · Cited by 14

Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer

Woodward, E. R., van Veen, E. M., Forde, C., Harkness, E. F., Byers, H., Ellingford, J. M., Burghel, G. J., Schlech, H., Bowers, N. L., Wallace, A. J., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01234-6 · Cited by 16

Bayesian Semiparametric Estimation of Cancer-Specific Age-at-Onset Penetrance With Application to Li-Fraumeni Syndrome

Shin, S. J., Yuan, Y., Strong, L. C., Bojadzieva, J., & Wang, W. (2018) · Journal of the American Statistical Association · doi:10.1080/01621459.2018.1482749 · Cited by 14

The BRCA2 polymorphic stop codon: stuff or nonsense?

Higgs, J. E., Harkness, E. F., Bowers, N. L., Howard, E., Wallace, A. J., Lalloo, F. I., Newman, W. G., & Evans, D. G. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103206 · Cited by 13

New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer

Evans, D. G., & Woodward, E. R. (2020) · Familial Cancer · doi:10.1007/s10689-020-00207-z · Cited by 15

The dichotomy of p53 regulation by noncoding RNAs

Deng, Q., Becker, L., Ma, X., Zhong, X., Young, K. H., Ramos, K. S., & Li, Y. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju017 · Cited by 14

The art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure.

Walker, J. R., Singal, P. K., & Jassal, D. S. (2009) · PubMed Central · Cited by 12

A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland

McVeigh, T. P., Sweeney, K., Brennan, D. J., McVeigh, U. M., Ward, S., Strydom, A., Seal, S., Astbury, K., Donnellan, P. P., Higgins, J., et al. (2022) · Familial Cancer · doi:10.1007/s10689-022-00313-0 · Cited by 11

No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways

Penkert, J., Schlegelberger, B., Steinemann, D., & Gadzicki, D. (2012) · Familial Cancer · doi:10.1007/s10689-012-9556-0 · Cited by 10

p53 in the Clinics

Hainaut, P. L., Wiman, K. G., & Olivier, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8 · Cited by 10

Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome

Shin, S. J., Li, J., Ning, J., Bojadzieva, J., Strong, L. C., & Wang, W. (2018) · Biostatistics · doi:10.1093/biostatistics/kxy066 · Cited by 10

What Animal Cancers teach us about Human Biology

Kattner, P., Zeiler, K., Herbener, V. J., Ferla-Brühl, K. L., Kassubek, R., Grunert, M., Burster, T., Brühl, O., Weber, A. S., Strobel, H., et al. (2021) · Theranostics · doi:10.7150/thno.56623 · Cited by 11

Development of a Scoring System to Screen for BRCA1/2 Mutations

Evans, D. G., & Lalloo, F. I. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-759-4_14 · Cited by 9

Cancer predisposition syndromes associated with myeloid malignancy

Quinn, E. A., & Nichols, K. E. (2017) · Seminars in Hematology · doi:10.1053/j.seminhematol.2017.04.003 · Cited by 9

Apparently “BRCA-Related” Breast and Ovarian Cancer Patient With Germline TP53 Mutation

Janavičius, R., Andrėkutė, K., Mickys, U., Rudaitis, V., Brasiūnienė, B., & Griškevičius, L. (2011) · The Breast Journal · doi:10.1111/j.1524-4741.2011.01088.x · Cited by 9

Interpretation of ambiguous TP53 test results: Mosaicism, clonal hematopoiesis, and variants of uncertain significance

Berry, D. K., Gillis, N., Padron, E., Moore, C. E., Barton, L., Gewandter, K. R., Haskins, C. G., & Knepper, T. C. (2023) · Journal of Genetic Counseling · doi:10.1002/jgc4.1789 · Cited by 8

Clinical characteristics and registry-validated extended pedigrees of germline TP53 mutation carriers in Denmark

Stoltze, U. K., Skytte, A., Roed, H., Hasle, H., Ejlertsen, B., Hansen, T. V. O., Schmiegelow, K., Gerdes, A., & Wadt, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190050 · Cited by 8

Epidemiology and Etiology of Childhood ALL

Tulstrup, M., Stoltze, U. K., Schmiegelow, K., & Yang, J. J. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-39708-5_1 · Cited by 8

Bioinformatic analysis reveals the key pathways and genes in early-onset breast cancer

Cui, C., Li, L., & Zhen, J. (2018) · Medical Oncology · doi:10.1007/s12032-018-1130-7 · Cited by 8

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability

Evans, D. G., van Veen, E. M., Woodward, E. R., Harkness, E. F., Ellingford, J. M., Bowers, N. L., Wallace, A. J., Howell, S. J., Howell, A., Lalloo, F. I., et al. (2021) · Cancers · doi:10.3390/cancers13164154 · Cited by 8

A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families

Llovet, P., Illana, F. J., Martín-Morales, L., de la Hoya, M., Garré, P., Ibañez-Royo, M. D., Pérez‐Segura, P., Caldés, T., & García‐Barberán, V. (2017) · Familial Cancer · doi:10.1007/s10689-017-9990-0 · Cited by 8

Genetic Factors

Walsh, M. F., Cadoo, K. A., Salo‐Mullen, E. E., Dubard-Gault, M. E., Stadler, Z. K., & Offit, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00013-x · Cited by 10

Screening for BRCA1 large genomic rearrangements in female Egyptian hereditary breast cancer patients

Hagag, E., Shwaireb, M. H., Coffa, J., & Wakil, A. E. (2013) · Eastern Mediterranean Health Journal · doi:10.26719/2013.19.3.255 · Cited by 8

Men seeking counselling in a Breast Cancer Risk Evaluation Clinic

Freitas, A. C., Opinião, A., Fragoso, S., Nunes, H., Santos, M., Clara, A. I., Bento, S., Luis, A. S., Silva, J. A. M. D. C., Moura, C., et al. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.804 · Cited by 8

Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil

Bittar, C. M., Rocha, Y. M. D. A., Vieira, I. A., Rosset, C., Andreis, T. F., Sartor, I. T. S., Artigalás, O., Netto, C. B. O., Alemar, B., Macedo, G. S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251639 · Cited by 7

Epidemiology and Etiology of Cancer in Adolescents and Young Adults

Birch, J. M., & Bleyer, A. (2007) · Springer eBooks · doi:10.1007/978-3-540-68152-6_3 · Cited by 7

Low Prevalence of BRCA1 Exon Rearrangements in Familial and Young Sporadic Breast Cancer Patients

Ellis, D., Patel, Y., Yau, S. C., Hodgson, S. V., & Abbs, S. J. (2006) · Familial Cancer · doi:10.1007/s10689-006-0001-0 · Cited by 6

Concern regarding classification of germline TP53 variants as likely pathogenic

Evans, D. G., Turnbull, C., & Woodward, E. R. (2019) · Human Mutation · doi:10.1002/humu.23750 · Cited by 6

4-Hydroxyestradiol Induces ^|^gamma;-H2AX in the Presence of an Inhibitor of Catechol-O-methyltransferase in Human Breast Cancer MCF-7 Cells

Yamazaki, S., Sakakibara, H., Takemura, H., & Shimoi, K. (2012) · Genes and Environment · doi:10.3123/jemsge.34.129 · Cited by 5

Li–Fraumeni Syndrome

Malkin, D. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_11 · Cited by 5

Applying molecular epidemiology in pediatric leukemia

Schiffman, J. D. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000204 · Cited by 5

Hereditary Cancer Syndrome Recognition and Testing: Beyond BRCA

Himes, D. O., & Shuman, H. (2020) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2020.03.015 · Cited by 5

LI-FRAUMENI SYNDROME IN A TURKISH FAMILY

Karakaş, Z., Tuğcu, D., Ünüvar, A., Atay, D., Akçay, A., Gedik, H., Kayserili, H., Doğan, Ö., Anak, S. S., & Devecioğlu, Ö. (2010) · Pediatric Hematology and Oncology · doi:10.3109/08880011003663374 · Cited by 6

Patterns of Incidence of Cancer in Teenagers and Young Adults: Implications for Aetiology

Birch, J. M. (2005) · doi:10.1002/9780470994733.ch2 · Cited by 5

Precision Prevention: The Current State and Future of Genomically Guided Cancer Prevention

Kassem, N., Stout, L. A., Hunter, C., Schneider, B., & Radovich, M. (2020) · JCO Precision Oncology · doi:10.1200/po.19.00278 · Cited by 5

Landscape of somatic mutated genes and inherited susceptibility genes in gynecological cancer

Watanabe, T., Soeda, S., Okoshi, C., Fukuda, T., Yasuda, S., & Fujimori, K. (2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15766 · Cited by 4

LFSPROShiny: An Interactive R/Shiny App for Prediction and Visualization of Cancer Risks in Families With Deleterious Germline TP53 Mutations

Nguyen, N. H., Dodd-Eaton, E. B., Peng, G., Corredor, J. L., Jiao, W., Woodman-Ross, J., Arun, B., & Wang, W. (2024) · JCO Clinical Cancer Informatics · doi:10.1200/cci.23.00167 · Cited by 4

Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers

Boruah, N., Hoyos, D., Moses, R., Hausler, R. M., Desai, H., Le, A. D., Good, M., Kelly, G., Raghavakaimal, A., Tayeb, M. N., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73163-4 · Cited by 4

Genetic predisposition to cancer

Evans, D. G. (2011) · Medicine · doi:10.1016/j.mpmed.2011.09.013 · Cited by 4

Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li-Fraumeni syndrome and Cowden syndrome

Robays, J., Stordeur, S., Hulstaert, F., Maerken, T. V., Claes, K., Janin, N., Matthijs, G., de Roodenbeke, D. '. K., Berlière, M., Wildiers, H. P. M. W., et al. (2015) · doi:10.57598/r236c · Cited by 4

Genetic predisposition to cancer

Evans, D. G. (2008) · Medicine · doi:10.1016/j.mpmed.2007.10.004 · Cited by 4

Hereditary Breast Cancer: BRCA and Other Susceptibility Genes

Azzollini, J., Fontana, L., & Manoukian, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-41207-4_3 · Cited by 3

Inherited Risk for Childhood Leukemia

Vagher, J., Maese, L. D., Gammon, A., Kohlmann, W. K., & Schiffman, J. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-74448-9_11 · Cited by 3

BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families

Azzouzi, A., Stoppa‐Lyonnet, D., Morgan Rouprêt, A., Larré, S., Mangin, P., & Cussenot, O. (2007) · International Journal of Urology · doi:10.1111/j.1442-2042.2006.01712.x · Cited by 3

Bayesian Semiparametric Estimation of Cancer-Specific Age-at-Onset Penetrance With Application to Li-Fraumeni SyndromePreprint

Shin, S. J., Yuan, Y., Strong, L. C., Bojadzieva, J., & Wang, W. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1701.01558 · Cited by 3

What Should a Gynecologist Know about Li-Fraumeni Syndrome? Lessons from a Patient Undergoing Hysterectomy for Benign Indications

Advolodkina, P., Lachiewicz, M. P., Oprea‐Ilies, G., Majmudar, B., & Gordon, A. N. (2018) · Gynecologic and Obstetric Investigation · doi:10.1159/000489261 · Cited by 2

Evaluation of whole-body MRI for cancer early detection in Li-Fraumeni syndrome

Sodde, P., Hyder, Z., Pugh, S., Lalloo, F. I., Martin, R., Soh, C., Naqvi, J., Whitehouse, R. W., Evans, D. G., & Woodward, E. R. (2025) · Journal of Medical Genetics · doi:10.1136/jmg-2025-110704 · Cited by 2

Li-Fraumeni Syndrome

Villani, A., Frébourg, T., & Malkin, D. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-74448-9_1 · Cited by 2

Features of heritable TP53-related cancer syndrome

Stepanov, I., Vasilyeva, E., Соколенко, А. П., & Имянитов, Е. Н. (2022) · Voprosy Onkologii · doi:10.37469/0507-3758-2022-68-2-140-148 · Cited by 2

Molecular Analyses of Early-Onset Gastric Cancer in Brazilian Patients: TP53 Mutations, Cadherin-Catenin and Mucins Proteins Expression

da Silva, E. M., Fregnani, J. H. T. G., Martel‐Planche, G., da Costa, W. L., Coimbra, F. J. F., Achatz, M. I., Hainaut, P. L., & Soares, F. A. (2013) · Journal of Cancer Therapy · doi:10.4236/jct.2013.41a005 · Cited by 2

Familial Breast Cancer and Genetic Predisposition in Breast Cancer

Walavalkar, V., Khan, A. A., & Kandil, D. H. (2015) · Molecular pathology library · doi:10.1007/978-1-4939-2886-6_2 · Cited by 2

INHERITED GENETIC SUSCEPTIBILITY TO BREAST CANCER IN PAKISTAN

Muhammad, N., Nawaz, R., Khan, F. A., Naeemi, H., & Rashid, M. U. (2018) · Journal of Cancer & Allied Specialties · doi:10.37029/jcas.v4i2.179 · Cited by 2

Concerns of Hereditary Breast Cancer in Pregnancy and Lactation

Chen, J. H., Prasath, V., Axilbund, J. E., & Habibi, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-41596-9_17 · Cited by 2

A Case-Based Approach to Understanding Complex Genetic Information in an Evolving Landscape

Dinardo, C. D., Korde, L. A., & Yurgelun, M. B. B. (2021) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_321041 · Cited by 2

Clinical Features and Treatment Strategies of Li‐Fraumeni Syndrome Patients With Inherited TP53 Mutations

Chen, K., Xu, Y., Song, B., Gu, Y., Xu, X., Cao, J., & Fang, M. (2026) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70177 · Cited by 1

Hereditäre Tumorsyndrome in der Neuropathologie

Mawrin, C. (2017) · Der Pathologe · doi:10.1007/s00292-017-0292-y · Cited by 1

Hereditary Breast Cancer Genetics and Risk Prediction Techniques

Carley, H., & Kulkarni, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-56673-3_5 · Cited by 1

Preventive and Predictive Genetics: A perspective

Grech, G., Scerri, C. A., Scerri, J., & Cesuroğlu, T. (2015) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-319-15344-5_2 · Cited by 1

Biology and Etiology of Rare Pediatric Tumors

Brecht, I. B., & Merks, J. H. M. (2011) · Pediatric oncology · doi:10.1007/978-3-642-04197-6_5 · Cited by 1

ALTERATION IN SERUM LIPID PROFILE LEVELS IN IRAQI WOMEN WITH BREAST CANCER BEFORE AND AFTER CHEMOTHERAPY

Hamoode, R. H., Al-Ani, M. Q., & Turkey, F. A. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11i5.24423 · Cited by 1

Li-Fraumeni 症候群 −最新の報告から−

由記子, 恒. (2010) · doi:10.18976/jsft.10.2_75 · Cited by 1

Reply: Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian Cancer Research UK

Antoniou, A. C., Pharoah, P. D. P., Cunningham, A. P., & Easton, D. F. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602488 · Cited by 1

The cardioprotective role of flaxseed in the prevention of anthracycline and trastuzumab mediated cardiotoxicity

Asselin, C. Y. (2019) · Mspace (University of Manitoba) · Cited by 1

The Functional and Clinical Consequences of TP53 Mutations in Cancer

Fischer, N. W. (2019) · TSpace (University of Toronto) · Cited by 1

Personalized Risk Prediction for Cancer Survivors: A Bayesian Semi-parametric Recurrent Event Model with Competing OutcomesPreprint

Nguyen, N. H., Shin, S. J., Dodd-Eaton, E. B., Ning, J., & Wang, W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.28.530537 · Cited by 1

Modificadores de penetrância de mutações germinativas no gene TP53 em famílias brasileiras com diagnóstico clínico da síndrome de Li-Fraumeni e Li-Fraumeni like: impacto dos polimorfismos intragênicos do TP53 e de genes

Achatz, M. (2008) · doi:10.11606/t.5.2008.tde-29012009-172419

EVALUATION OF CURRENT CLINICAL CRITERIA FOR LI-FRAUMENI SYNDROME IN A DIVERSE SAMPLE OF TP53 MUTATION CARRIERS

Parham, E. A. (2014) · Digital Commons-TMC (Texas Medical Center)

Genetic factors in childhood cancer. Associations between tumors in childhood and adulthood, and prevalence of germline TP53 mutations

Magnusson, S. (2012) · Lund University Publications (Lund University)

Seasonality in the Incidence of Breast Cancer in Teenage and Young Adult Females in Northern England, 1968-2005

Basta, N. O. (2011) · The Open Breast Cancer Journal · doi:10.2174/1876817201103010006

Inherited Cancer-Predisposing Syndomes

Hodgson, S. V., Foulkes, W. D., Eng, C., & Maher, E. R. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2375-0_11

Li-Fraumeni syndrome, clinical and molecular genetics

Ruijs, M. (2010) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)

The Inheritance of p53

Grochola, L. F., Zerón-Medina-Cuairán, J., Repapi, E., Finlayson, A. E. T., Cai, Y., Atwal, G. S., & Bond, G. L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8_2

The Genetic Epidemiology of Hereditary Breast Cancer

Easton, D. F., Antoniou, A. C., & Thompson, D. J. (2007) · CRC Press eBooks · doi:10.3109/9781420020366-2

Malignant disease of the breast

Thiruchelvam, P. T. R., Svensson, W. E., & Lynn, J. T. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3120-5.00047-3

Biomarkers for Early Detection of Familial Breast Cancer

Yılmaz, B., Moroski-Erkul, C. A., Hatipoğlu, Ö. F., Gündüz, E., Barh, D., & Gündüz, M. (2015) · CRC Press eBooks · doi:10.1201/b18015-8

Investigation of PIN1 as a Genetic Modifier in Li-Fraumeni Syndrome

Villani, A. (2015) · TSpace (University of Toronto)

Li-Fraumeni 症候群患者にサーベイランスとして施行したPET/CT で早期に肺癌を発見し手術し得た一例

真, 田., 省三, 大., 清藤, 佐., 三奈, 高., 青儀健二郎, 澤田, 茂., 素弘, 山., 田村和朗, 秋澤叔香, 加代子, 斎., et al. (2017) · doi:10.18976/jsft.17.1_22

Hymenoptera anaphylaxis: indications and results of immunotherapy

Müller, U. R., & Helbling, A. (2014) · doi:10.2217/fmeb2013.13.25

Patched Domain-containing 4 (PTCH53) Identified in Li-Fraumeni Syndrome Patient-derived Cells

Pan, A. (2018) · TSpace (University of Toronto)

Hereditary Breast Cancer in Selected Populations: Screening RECQL Gene in Ontario, Canada, and Exploring BRCA1/2 and PALB2 in the Caribbean

Ahmed, H. (2018) · TSpace (University of Toronto)

Breast Cancer Risk Assessment and Genetic Testing

Arora, N., & Mehta, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-3438-2_29

Genetic Counseling for Pancreatic Cancer

Geurts, J. L. (2019) · Springer eBooks · doi:10.1007/978-3-319-98944-0_13

Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling

Webster, R. D., Bannon, S. A., Hyde, S. M., Woodson, A., You, N., Lu, K. H., & Arun, B. (2019) · Wiley eBooks · doi:10.1002/9781119000822.hfcm143

TP53 Germline Mutations are Associated with HR+/HER2+ in BRCA1/2-Negative Early-Onset Breast Cancer in ChinaPreprint

Chen, L., Huang, M., Chen, M., Lin, Y., Li, J., Guo, W., Wang, C., & Fu, F. (2022) · Research Square · doi:10.21203/rs.3.rs-1200021/v1

TP53 germline mutations are associated with HR+/HER2+ in BRCA1/2-negative early-onset breast cancer in ChinaPreprint

Fu, F., Chen, L., Huang, M., Chen, M., Lin, Y., Li, J., Guo, W., & Wang, C. (2022) · Research Square · doi:10.21203/rs.3.rs-1200021/v2

Biology and Etiology of Rare Pediatric Tumors

Brecht, I. B., & Merks, J. H. M. (2022) · Pediatric oncology · doi:10.1007/978-3-030-92071-5_3

Other Syndromes

Walsh, C., & Strong, L. C. (2008) · CRC Press eBooks · doi:10.3109/9781420052886-16

TP53 germline mutations are associated with HR+/HER2+ in BRCA1/2-negative early-onset breast cancer in ChinaPreprint

Chen, L., Huang, M., Chen, M., Lin, Y., Li, J., Guo, W., Wang, C., & Fu, F. (2022) · Research Square · doi:10.21203/rs.3.rs-1200021/v3

Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling

Bluebond, R., Bannon, S. A., Hyde, S. M., Woodson, A., You, N., Lu, K. H., & Arun, B. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm143.pub2

Clinicopathologic and Molecular Subtyping of EGFR Mutation—Response

Jung, H. A., Lim, J., Choi, Y., Kim, J., & Park, K. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3549

Low prevalence of germline TP53 and PALB2 mutations in unselected cohort of breast cancer patients from Brunei Darussalam

Matusin, S. N. I., Lu, Z. H., & Hamid, M. R. W. H. A. (2023) · F1000Research · doi:10.12688/f1000research.136362.1

Cancer Genetics

Dagar, A., Bharat, R., & Mallick, S. (2025) · Springer eBooks · doi:10.1007/978-981-96-4872-6_16

Genetic Counseling for TP53 Germline Mutations

Achatz, M. I., & Ashton‐Prolla, P. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8_18

Other Hereditary Breast Cancer Syndromes and Genes

Nathanson, K. L. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0477-5_7

BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives

Lalloo, F. I., Varley, J. M., Moran, A., Ellis, D., O’Dair, L., Pharoah, P. D. P., Antoniou, A. C., Hartley, R., Shenton, A., Seal, S., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.032 · Cited by 175

Inverse association between age at the time of radiation exposure and extent of disease in cases of radiation-induced childhood thyroid carcinoma in Belarus

Farahati, J., Demidchik, E. P., Biko, J., & Reiners, C. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000315)88:6 · Cited by 76

Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: A population‐based study

de Sanjosé, S., Léoné, M., Berez, V., Izquierdo, Á., Font, R., Brunet, J., Louat, T., Vilardell, L., Borràs, J., Viladiu, P., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11271 · Cited by 114

Population-Based Estimate of the Contribution of TP53 Mutations to Subgroups of Early-Onset Breast Cancer: Australian Breast Cancer Family Study

Mouchawar, J., Korch, C. T., Byers, T., Pitts, T. M., Li, E., McCredie, M. R. E., Giles, G. G., Hopper, J. L., & Southey, M. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-0851 · Cited by 92

Hereditary Susceptibility to Breast Cancer: Significance of Age of Onset in Family History and Contribution of BRCA1 and BRCA2

Frank, T. S., Deffenbaugh, A. M., Hulick, M., & Gumpper, K. (2002) · Disease Markers · doi:10.1155/1999/291023 · Cited by 11